To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

CANCER CONTROVERSY

Oncologists not prescribing expensive cancer drugs

By Christine Blank
In the latest controversy over the high cost of certain prescription medications, a recent Reuters article said that more oncologists won’t prescribe expensive drugs. Why not?

Injectable schizophrenia drug gets FDA green light

by Erin Bastick
FDA has approved aripiprazole lauroxil (Aristada, Alkermes) extended-release injectable suspension for the treatment of adults with schizophrenia. Study details

CONTINUING EDUCATION

October 2015
MTM essentials for cold, flu, and sinusitis management

Session code: 15DT35-PTK48
This month’s CE activity is part of the CPE series, "Medication Therapy Management for the Patient with Respiratory Disease." From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to compare and contrast the common cold, influenza, and sinusitis, and discuss the role of the pharmacist as the medication expert for various treatment options and as a source to triage patients when needed.

To read and print the article with TEST QUESTIONS, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 15DT35-PTK48.
Copy the session code — 15DT35-PTK48 — before logging into the Online CE Center. When the page for the Online CE Center opens, paste the session code into the appropriate field, under your NABP ID.

EDITOR'S PICK

3 top concerns with IPF and comorbidities (SLIDESHOW)

by Christine Blank
Patients with IPF should be carefully assessed for comorbidities, the most significant of which are cardiovascular disease and lung cancer. Read more

October 16, 2015

Related Articles

Keytruda for lung cancer gets accelerated approval

Long-acting schizophrenia drug may help with medication adherence

Resources

Get the latest FormularyWatch updates on drug approvals, current studies, and other findings.

Click for the latest Clinical News

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters